Full Text
POSB201 Effectiveness and Safety of Low Versus High Dose Rivaroxaban and Apixaban for Atrial Fibrillation: Propensity Score-Matched Cohort Study

Abstract

Authors

S Perreault A Dragomir A Lenglet M Dorais

Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×